IN172160B - - Google Patents

Info

Publication number
IN172160B
IN172160B IN296/MAS/91A IN296MA1991A IN172160B IN 172160 B IN172160 B IN 172160B IN 296MA1991 A IN296MA1991 A IN 296MA1991A IN 172160 B IN172160 B IN 172160B
Authority
IN
India
Application number
IN296/MAS/91A
Other languages
English (en)
Inventor
Salimbeni Aldo
Manghishi Elso
Caliari Saturnino
Fici Francesco
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of IN172160B publication Critical patent/IN172160B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IN296/MAS/91A 1990-04-27 1991-04-15 IN172160B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20160A IT1240686B (it) 1990-04-27 1990-04-27 Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
PCT/EP1991/000742 WO1991017153A1 (en) 1990-04-27 1991-04-18 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use

Publications (1)

Publication Number Publication Date
IN172160B true IN172160B (fi) 1993-04-17

Family

ID=11164306

Family Applications (1)

Application Number Title Priority Date Filing Date
IN296/MAS/91A IN172160B (fi) 1990-04-27 1991-04-15

Country Status (20)

Country Link
US (1) US5571807A (fi)
EP (1) EP0526495A1 (fi)
JP (1) JPH05506654A (fi)
CN (1) CN1056101A (fi)
AU (1) AU645317B2 (fi)
BG (1) BG97014A (fi)
BR (1) BR9106372A (fi)
CA (1) CA2081204A1 (fi)
CS (1) CS120991A2 (fi)
FI (1) FI924756A (fi)
HU (1) HU9203326D0 (fi)
IE (1) IE71033B1 (fi)
IL (1) IL97859A0 (fi)
IN (1) IN172160B (fi)
IT (1) IT1240686B (fi)
MA (1) MA22143A1 (fi)
PT (1) PT97508A (fi)
RO (1) RO111269B1 (fi)
WO (1) WO1991017153A1 (fi)
ZA (1) ZA913171B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118292T3 (es) * 1994-09-16 1998-09-16 Orion Corp Fermion Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
US5559229A (en) * 1995-06-01 1996-09-24 Acic (Canada) Inc. Method for the manufacture of benzothiazepine
WO2006079077A2 (en) * 2005-01-20 2006-07-27 Acadia Pharmaceuticals Inc. Use of diltiazem or analogs thereof as modulators of ghrelin receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
IT1206505B (it) * 1983-07-22 1989-04-27 Schiapparelli Farma Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
ES2038668T3 (es) * 1986-08-20 1993-08-01 Mcneilab, Inc. Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
ATE116643T1 (de) * 1989-04-28 1995-01-15 Tanabe Seiyaku Co Verfahren zur herstellung von 1,5- benzothiazepinderivaten.
JPH085869B2 (ja) * 1990-03-08 1996-01-24 田辺製薬株式会社 １，５−ベンゾチアゼピン誘導体の製法

Also Published As

Publication number Publication date
IT9020160A0 (it) 1990-04-27
IL97859A0 (en) 1992-06-21
AU7695491A (en) 1991-11-27
AU645317B2 (en) 1994-01-13
IT1240686B (it) 1993-12-17
WO1991017153A1 (en) 1991-11-14
BR9106372A (pt) 1993-04-27
IT9020160A1 (it) 1991-10-27
EP0526495A1 (en) 1993-02-10
MA22143A1 (fr) 1991-12-31
CN1056101A (zh) 1991-11-13
CS120991A2 (en) 1991-12-17
RO111269B1 (ro) 1996-08-30
PT97508A (pt) 1992-01-31
JPH05506654A (ja) 1993-09-30
IE911411A1 (en) 1991-11-06
ZA913171B (en) 1992-02-26
CA2081204A1 (en) 1991-10-28
US5571807A (en) 1996-11-05
IE71033B1 (en) 1997-01-15
FI924756A0 (fi) 1992-10-20
HU9203326D0 (en) 1993-01-28
FI924756A (fi) 1992-10-20
BG97014A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
FR2659180B1 (fi)
DE4190037T (fi)
DE4192351T (fi)
EP0453641A3 (fi)
FR2657420B1 (fi)
FR2659072B1 (fi)
FR2658018B1 (fi)
ATA127191A (fi)
DE4092603T (fi)
FR2660748B1 (fi)
ECSM90402U (fi)
ECSM90422U (fi)
ECSM90440U (fi)
ECSM90455U (fi)
ECSM90467U (fi)
ECSM90414U (fi)
ECSM90398U (fi)
DK285090D0 (fi)
IN174746B (fi)
IN174915B (fi)
EP0461336A3 (fi)
EP0533929A4 (fi)
EP0454926A3 (fi)
EP0448025A3 (fi)
EP0463550A3 (fi)